Clinical diagnosis: Chronic hepatitis, steatosis. Is a 3-surgical department of Moscow City Clinical Hospital № 70. CBC: Hb-140 g / l, erythrocytes, 4.14, WBC-7.6, P-14%, S/ya-56%, O-1% M-6%, L-21% Platelets-319, MCV -27 mm / hr Blood biochemistry: protein 64 g / L, urea 6.1 mmol / L, creatinine of 77 umol / L, bilirubin 8.1-3.0-5.1 mmol / l, glucose 6.56 mmol / L, ALT 68, AST-45, A- amylase-35. RW, HbsAg, aHCV, HIV - negative. Chest X-ray: no abnormalities. Colonoscopy: Pathology in the colon were found. Endoscopy: superficial gastritis abdominal ultrasonography: hepatomegaly, diffuse changes of the liver. Is it possible for data analysis, the genotype of HCV, the possibility of treating a disease what drugs, the timing and the minimum price of treatment.

Respond Bakulin Igor G., hepatology, gastroenterology, hepatology and gastroenterology clinic Medal solely on the basis of laboratory and instrumental data previously possible to speak about non-alcoholic steatogeatite, minimal activity. Such genotypes in hepatitis is not classified. Basic drugs can be considered essential phospholipids (Essentiale, Esliver, Phosphogliv) and ursodeoxycholic acid. Timing of treatment is determined according to performance (but not less than 3 months). For the full picture you need to know about the presence of so-called metabolic syndrome (body mass, blood levels of cholesterol and triglycerides, glucose, insulin), to have data on the availability of alcohol history may be more extensive virological investigations. Similar question: ... at Westergren ... Biochemistry of blood: 2.1. IN HOSPITAL ... Mr. Bilirubin, mmol / L = 19 Alpha Amylase CPK = 177 MW = 177 Total protein, g / l = 78 Urea, mmol / L = 8.1 Creatinine, mmol / L = 152 ALT, U / L = 14, AST, U / l ...